Burning Rock Biotech Limited (NASDAQ:BNR – Get Free Report) shot up 0.4% on Tuesday . The stock traded as high as $7.15 and last traded at $6.87. 155 shares changed hands during trading, a decline of 97% from the average session volume of 4,583 shares. The stock had previously closed at $6.84.
Burning Rock Biotech Stock Up 0.4 %
The company has a fifty day moving average of $6.98 and a two-hundred day moving average of $7.67. The stock has a market capitalization of $70.35 million, a price-to-earnings ratio of -1.06 and a beta of 0.17.
Burning Rock Biotech (NASDAQ:BNR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 29th. The company reported ($0.16) earnings per share for the quarter. Burning Rock Biotech had a negative return on equity of 71.22% and a negative net margin of 113.39%. The company had revenue of $17.40 million for the quarter.
Institutional Inflows and Outflows
Burning Rock Biotech Company Profile
Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples.
Featured Stories
- Five stocks we like better than Burning Rock Biotech
- What Investors Need to Know About Upcoming IPOs
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Buy P&G Now, Before It Sets A New All-Time High
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What to Know About Investing in Penny Stocks
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Burning Rock Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burning Rock Biotech and related companies with MarketBeat.com's FREE daily email newsletter.